NSEAnalysts/Institutional Investor Meet/Con. Call Updates3d ago · 3 Aug 2026, 11:48 am
Analysts/Institutional Investor Meet/Con. Call Updates
Aarti Pharmalabs Limited · AARTIPHARM
✦ AI SummaryResults
Aarti Pharmalabs Limited has informed the Exchange about the schedule of an earnings conference call to discuss the Q1 FY27 financial results.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
AARTIPHARMA_03082026114744_Intimation_APLsigned.pdf
View document text
August 03, 2026
To, To,
Listing/ Compliance Department Listing/ Compliance Department
BSE LTD. National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1,
Dalal Street, G Block, Bandra Kurla Complex,
Mumbai - 400 001 Bandra (E), Mumbai – 400 051
SCRIP CODE: 543748 SYMBOL: AARTIPHARM
Dear Sir/Madam,
Sub: Intimation of Earnings Conference Call
Ref: Regulation 30 of the SEBI (LODR)
Regulations, 2015
This is to inform you that the Earnings Conference Call for investors and analysts has been
scheduled for Monday, August 10, 2026, at 4:00 P.M. (IST) to discuss the Company’s Q1
FY27 financial results.
Please find attached herewith Invitation for the same.
Kindly take the same on your record.
Thanking you,
Yours faithfully,
For AARTI PHARMALABS LIMITED
JEEVAN MONDKAR
COMPANY SECRETARY AND LEGAL HEAD
ICSI M. NO. A22565
Encl. a/a.
CONCALL INVITE
360 ONE CM Research shall hold
a Conference Call of
Aarti Pharmalabs Limited
to discuss the 1QFY27 Results
on Monday, 10th August 2026 at 16:00 Hrs IST
The Management Team will be represented by:
Mr. Rashesh Gogri – Chairman
Ms. Hetal Gogri Gala - Vice Chairperson & Managing Director
Mr. Piyush Lakhani – Chief Financial Officer
You are cordially invited
Diamond Pass Link
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0531503&linkSecuritySt
ring=4920a08ab
Universal Dial-in Numbers
+91 22 6280 1222 / +91 22 7115 8123
International Toll Free:
Argentina: 0080014243444 | Australia: 0080014243444 | Belgium: 0080014243444 | Canada: 01180014243444
China: 4008428405 | | France: 0800914745 | Germany: 0080014243444 | Hong Kong: 800964448
Italy: 0080014243444 | Japan: 00531161110 | Netherlands: 08000229808 | Poland: 008001124248
Singapore: 8001012045 | South Korea: 00180014243444 | Sweden: 0080014243444
Thailand: 00180014243444 | UK: 08081011573 | USA: 18667462133
For further information, please contact
Mr. Rohit Bhat / Mr. Maulik Varia
360 ONE Capital Market Research
+91 22 4031 7150 / +91-22-4031 7275
rohit.bhat@360.one / maulik.varia@360.one